Pharmacokinetics of mycophenolic acid in the early period after kidney transplantation
- 1 December 1998
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 30 (8) , 4090-4091
- https://doi.org/10.1016/s0041-1345(98)01352-9
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Drug monitoring of mycophenolic acid in the early period after renal transplantationTransplantation Proceedings, 1998
- A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1996
- Pharmacokinetics and Bioavailability of Mycophenolate Mofetil in Healthy Subjects after Single‐Dose Oral and Intravenous AdministrationThe Journal of Clinical Pharmacology, 1996
- MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF REFRACTORY, ACUTE, CELLULAR RENAL TRANSPLANT REJECTION1Transplantation, 1996
- Mycophenolate Mofetil: A Report of the Consensus PanelTherapeutic Drug Monitoring, 1995
- MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1995
- Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejectionThe Lancet, 1995